0001140361-23-001815.txt : 20230117 0001140361-23-001815.hdr.sgml : 20230117 20230117161311 ACCESSION NUMBER: 0001140361-23-001815 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20230117 ITEM INFORMATION: Material Modifications to Rights of Security Holders ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230117 DATE AS OF CHANGE: 20230117 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Eargo, Inc. CENTRAL INDEX KEY: 0001719395 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 273879804 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39616 FILM NUMBER: 23531682 BUSINESS ADDRESS: STREET 1: 2665 NORTH FIRST STREET STREET 2: SUITE 300 CITY: SAN JOSE STATE: CA ZIP: 95134 BUSINESS PHONE: 650-351-7700 MAIL ADDRESS: STREET 1: 2665 NORTH FIRST STREET STREET 2: SUITE 300 CITY: SAN JOSE STATE: CA ZIP: 95134 8-K 1 brhc10046632_8k.htm 8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


 FORM 8-K
 

CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 17, 2023
 

EARGO, INC.
(Exact name of registrant as specified in its charter)


 
Delaware
001-39616
27-3879804
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)

     
2665 North First Street, Suite 300
San Jose, California
 
95134
(Address of principal executive offices)
 
(Zip Code)

Registrant’s telephone number, including area code: (650) 351-7700
 
Not Applicable
(Former name or former address, if changed since last report)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
 
Trading
Symbol(s)
 
Name of each exchange
on which registered:
Common Stock, $0.0001 par value per share
 
EAR
 
The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐



Item 3.03.
Material Modification to Rights of Security Holders.
 
The information set forth in Item 5.03 of this Current Report on Form 8-K (this “Current Report”) is incorporated by reference into this Item 3.03.
 
Item 5.03.
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
 
On January 17, 2023, Eargo, Inc. (the “Company”) filed with the Secretary of State of the State of Delaware a Certificate of Amendment (the “Amendment”) to the Company’s Amended and Restated Certificate of Incorporation to effect a 1-for-20 reverse stock split of the Company’s common stock (the “Reverse Stock Split”) which became effective upon the filing of the Amendment (the “Effective Time”). The Amendment provides that, at the Effective Time, every 20 shares of the Company’s issued and outstanding common stock were automatically reclassified into one issued and outstanding share of common stock, without any change in par value per share, which remained $0.0001. No fractional shares will be issued as a result of the Reverse Stock Split. Stockholders who would otherwise be entitled to receive a fractional share are entitled to a cash payment in lieu of such fractional share. Proportionate adjustments were made to the number of shares of common stock reserved for issuance and other share limits under the Company’s equity incentive plans and employee stock purchase plan, and to the number of shares underlying outstanding equity awards and the per share exercise price of outstanding options.
 
The Company’s common stock is expected to begin trading on a split-adjusted basis on The Nasdaq Stock Market LLC (“Nasdaq”) at market open on January 18, 2023. The trading symbol for the common stock will remain “EAR.” The Company’s post-Reverse Stock Split common stock has a new CUSIP number (CUSIP No. 270087208).
 
The summary of the Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Amendment, a copy of which is attached hereto as Exhibit 3.1 and is incorporated by reference herein.
 
Item 8.01
Other Events.
 
On January 17, 2023, the Company issued a press release to announce the filing of the Amendment with the Secretary of State of the State of Delaware to effect the Reverse Stock Split. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.
 
Item 9.01.
Financial Statements and Exhibits.
 
(d) Exhibits.

Exhibit
No.
 
Description
 
Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Eargo, Inc.
 
Press Release dated January 17, 2023 titled “Eargo Effects 1-for-20 Reverse Stock Split.”
104
 
Cover Page Interactive Data File (embedded within the Inline XBRL document)


Forward-Looking Statements
 
This Current Report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact contained in this Current Report are forward-looking statements, including statements regarding the Company’s expectations regarding when the common stock will begin trading on a post-split basis on Nasdaq. Forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that could cause actual results and events to differ materially from those anticipated, including, but not limited to, risks, uncertainties and assumptions related to: the extent to which the Company may be able to validate processes to support the submission of claims for reimbursement from the FEHB program or other insurance programs in the future, if at all, and the Company’s ability to maintain or increase insurance coverage of Eargo hearing aids; the timing or results of ongoing claims audits and medical records reviews by third-party payors; the impact of third-party payor audits and the regulatory landscape for hearing aid devices on the Company’s business and results of operations; the Company’s expectations concerning additional orders by existing customers; the Company’s expectations regarding the potential market size and size of the potential consumer populations for its products and any future products, including insurance coverage of Eargo hearing aids; the Company’s ability to release new hearing aids and the anticipated features of any such hearing aids; developments and projections relating to the Company’s competitors and its industry, including competing products; the Company’s ability to maintain its competitive technological advantages against new entrants in its industry; the pricing of the Company’s hearing aids; the Company’s expectations regarding the ability to make certain claims related to the performance of its hearing aids relative to competitive products; the Company’s expectations with regard to changes in the regulatory landscape for hearing aid devices, including the implementation of the OTC hearing aid regulatory framework and the Company’s assessment, ability and timing for compliance with the new requirements; and the Company’s estimates regarding the COVID-19 pandemic, including, but not limited to, its duration and its impact on the Company’s business and results of operations. These and other risks are described in greater detail under the section titled “Risk Factors” contained in the Company’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q and the Company’s other filings with the Securities and Exchange Commission. Any forward-looking statements in this Current Report are made pursuant to the Private Securities Litigation Reform Act of 1995, as amended, are based on current expectations, forecasts and assumptions, and speak only as of the date of this Current Report. Except as required by law, the Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.
 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: January 17, 2023
EARGO, INC.
     
 
By:
/s/Adam Laponis
   
Adam Laponis
   
Chief Financial Officer



EX-3.1 2 brhc10046632_ex3-1.htm EXHIBIT 3.1

Exhibit 3.1

CERTIFICATE OF AMENDMENT
TO
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION
OF
EARGO, INC.
 
Eargo, Inc. (the “Corporation”), a corporation organized and existing under and by virtue of the Delaware General Corporation Law, hereby certifies as follows:
 

(a)
The name of the Corporation is Eargo, Inc. and the date on which the original Certificate of Incorporation of the Corporation was filed with the Secretary of State of the State of Delaware was November 12, 2010 (as subsequently amended and restated, the “Amended and Restated Certificate of Incorporation”).
 

(b)
This Certificate of Amendment to Amended and Restated Certificate of Incorporation has been duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.
 

(c)
This Certificate of Amendment to Amended and Restated Certificate of Incorporation amends the Amended and Restated Certificate of Incorporation of the Corporation to add the following as Section 3 of Article IV of the Amended and Restated Certificate of Incorporation:
 
Section 3. Upon the effectiveness of the filing of this Certificate of Amendment (the “Effective Time”) each number of shares of Common Stock either issued or outstanding or held by the Company as treasury stock, immediately prior to the Effective Time (the “Old Common Stock”) equal to the Reverse Split Number (as defined below) will be automatically reclassified as (without any further act) into one share of Common Stock (the “New Common Stock”) issued or outstanding or held by the Company as treasury stock (the “Reverse Stock Split”). The number of shares of Old Common Stock that shall be reclassified into one share of New Common Stock pursuant to the Reverse Stock Split shall be determined by the Board of Directors and publicly announced by the Company prior to the Effective Time (the “Reverse Split Number”). No fractional shares shall be issued as a result of or in connection with the Reverse Stock Split. In lieu of any fractional shares of New Common Stock to which any stockholder (or any beneficial owner of shares held through a bank, broker or other nominee) would otherwise be entitled as a result of the Reverse Stock Split, the Company shall pay an amount in cash equal to the product of: (i) such fraction of a share of New Common Stock, multiplied by (ii) the closing trading price of the Old Common Stock on the trading day immediately preceding the date of the Effective Time, multiplied by (iii) the Reverse Split Number. As soon as practicable following the Effective Time, the Company will cause the Company’s transfer agent and registrar to issue new book entries representing the number of shares of the New Common Stock into which such shares of Old Common Stock shall have been reclassified.”
 
IN WITNESS WHEREOF, Eargo, Inc. has caused this Certificate of Amendment to the Amended and Restated Certificate of Incorporation be signed by its duly authorized officer on this 17th day of January, 2023.
 
 
EARGO, INC.
   
 
 
By:
/s/ Christy La Pierre
 
Name:
  Christy La Pierre
 
Title:
  Chief Legal Officer and Secretary



EX-99.1 3 brhc10046632_ex99-1.htm EXHIBIT 99.1

Exhibit 99.1

Eargo Effects 1-for-20 Reverse Stock Split
 
SAN JOSE, Calif., Jan. 17, 2023 (GLOBE NEWSWIRE) – Eargo, Inc. (“Eargo” or the “Company”) (Nasdaq: EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today announced that it has filed a Certificate of Amendment (the “Amendment”) to its Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware to effect the previously announced 1-for-20 reverse stock split of the Company’s common stock (the “Reverse Stock Split”).
 
The Company’s common stock is expected to begin trading on a split-adjusted basis on The Nasdaq Stock Market LLC (“Nasdaq”) at market open on January 18, 2023. The Company’s common stock will continue to trade on Nasdaq under the trading symbol “EAR”, but will trade under the following new CUSIP number: 270087208.
 
As a result of the Reverse Stock Split, every 20 shares of common stock issued and outstanding as of the effective time of the Amendment will be automatically reclassified into one share of common stock. The Reverse Stock Split affects all stockholders uniformly and will not alter any stockholder’s percentage interest in the Company’s common stock, except to the extent that the Reverse Stock Split results in some stockholders owning a fractional share. No fractional shares will be issued as a result of the Reverse Stock Split. Stockholders of record who would otherwise be entitled to receive a fractional share are entitled to a cash payment in lieu of such fractional share.
 
As a result of the Reverse Stock Split, proportionate adjustments were made to the per share exercise price and the number of shares issuable upon the exercise or vesting of all outstanding stock options and restricted stock unit awards, which will result in a proportional decrease in the number of shares of the Company’s common stock reserved for issuance upon exercise or vesting of such stock options and restricted stock unit awards, and, in the case of stock options, a proportional increase in the exercise price of all such stock options. In addition, the number of shares reserved for issuance under the Company’s equity plans immediately prior to the effective time of the Amendment will be reduced proportionately.
 
The par value of the common stock will remain unchanged at $0.0001 per share after the Reverse Stock Split, and the number of authorized shares of common stock will remain at 450 million shares.
 
About Eargo
 
Eargo is a medical device company on a mission to improve hearing health. Our innovative products and go-to-market approach address the major challenges of traditional hearing aid adoption, including social stigma, accessibility and cost. We believe our Eargo hearing aids are the first virtually invisible, rechargeable, completely-in-canal, FDA-regulated devices indicated to compensate for mild to moderate hearing loss. Our differentiated, consumer-first approach empowers consumers to take control of their hearing. Consumers can purchase online, at retail locations or over the phone and get personalized and convenient consultation and support from hearing professionals via phone, text, email or video chat. Eargo hearing aids are offered to consumers at approximately half the cost of competing hearing aids purchased through traditional channels in the United States.
 

Related Links
http://eargo.com

Investor Contact
Nick Laudico
Senior Vice President of Corporate Strategy and Investor Relations
ir@eargo.com
 
Cautionary Statement Regarding Forward-Looking Statements
 
This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact contained in this press release are forward-looking statements, including statements regarding the Company’s expectations regarding when the common stock will begin trading on a post-split basis on Nasdaq. Forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that could cause actual results and events to differ materially from those anticipated, including, but not limited to, risks, uncertainties and assumptions related to: the extent to which the Company may be able to validate processes to support the submission of claims for reimbursement from the FEHB program or other insurance programs in the future, if at all, and the Company’s ability to maintain or increase insurance coverage of Eargo hearing aids; the timing or results of ongoing claims audits and medical records reviews by third-party payors; the impact of third-party payor audits and the regulatory landscape for hearing aid devices on the Company’s business and results of operations; the Company’s expectations concerning additional orders by existing customers; the Company’s expectations regarding the potential market size and size of the potential consumer populations for its products and any future products, including insurance coverage of Eargo hearing aids; the Company’s ability to release new hearing aids and the anticipated features of any such hearing aids; developments and projections relating to the Company’s competitors and its industry, including competing products; the Company’s ability to maintain its competitive technological advantages against new entrants in its industry; the pricing of the Company’s hearing aids; the Company’s expectations regarding the ability to make certain claims related to the performance of its hearing aids relative to competitive products; the Company’s expectations with regard to changes in the regulatory landscape for hearing aid devices, including the implementation of the OTC hearing aid regulatory framework and the Company’s assessment, ability and timing for compliance with the new requirements; and the Company’s estimates regarding the COVID-19 pandemic, including, but not limited to, its duration and its impact on the Company’s business and results of operations. These and other risks are described in greater detail under the section titled “Risk Factors” contained in the Company’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q and the Company’s other filings with the Securities and Exchange Commission. Any forward-looking statements in this press release are made pursuant to the Private Securities Litigation Reform Act of 1995, as amended, are based on current expectations, forecasts and assumptions, and speak only as of the date of this press release. Except as required by law, the Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.



EX-101.SCH 4 ear-20230117.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 5 ear-20230117_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Amendment Flag Document Fiscal Year Focus Document Fiscal Period Focus Document Period End Date Entity Registrant Name Entity Central Index Key Entity File Number Entity Tax Identification Number Entity Incorporation, State or Country Code Current Fiscal Year End Date Entity Emerging Growth Company Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name EX-101.PRE 6 ear-20230117_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 7 R1.htm IDEA: XBRL DOCUMENT v3.22.4
Document and Entity Information
Jan. 17, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jan. 17, 2023
Current Fiscal Year End Date --12-31
Entity File Number 001-39616
Entity Registrant Name EARGO, INC.
Entity Central Index Key 0001719395
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 27-3879804
Entity Address, Address Line One 2665 North First Street
Entity Address, Address Line Two Suite 300
Entity Address, City or Town San Jose
Entity Address, State or Province CA
Entity Address, Postal Zip Code 95134
City Area Code 650
Local Phone Number 351-7700
Title of 12(b) Security Common Stock, $0.0001 par value per share
Trading Symbol EAR
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
XML 8 brhc10046632_8k_htm.xml IDEA: XBRL DOCUMENT 0001719395 2023-01-17 2023-01-17 false --12-31 0001719395 8-K 2023-01-17 EARGO, INC. DE 001-39616 27-3879804 2665 North First Street Suite 300 San Jose CA 95134 650 351-7700 false false false false Common Stock, $0.0001 par value per share EAR NASDAQ false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.4 html 1 24 1 false 0 0 false 0 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://eargo.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports brhc10046632_8k.htm brhc10046632_ex3-1.htm brhc10046632_ex99-1.htm ear-20230117.xsd ear-20230117_lab.xml ear-20230117_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "brhc10046632_8k.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 24 }, "contextCount": 1, "dts": { "inline": { "local": [ "brhc10046632_8k.htm" ] }, "labelLink": { "local": [ "ear-20230117_lab.xml" ] }, "presentationLink": { "local": [ "ear-20230117_pre.xml" ] }, "schema": { "local": [ "ear-20230117.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2004/ref-2004-08-10.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/exch/2022/exch-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 30, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 24, "memberCustom": 0, "memberStandard": 0, "nsprefix": "ear", "nsuri": "http://eargo.com/20230117", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc10046632_8k.htm", "contextRef": "c20230117to20230117", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000100 - Document - Document and Entity Information", "menuCat": "Cover", "order": "1", "role": "http://eargo.com/role/DocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc10046632_8k.htm", "contextRef": "c20230117to20230117", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://eargo.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://eargo.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://eargo.com/role/DocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://eargo.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://eargo.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://eargo.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://eargo.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://eargo.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://eargo.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://eargo.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://eargo.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://eargo.com/role/DocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://eargo.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://eargo.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://eargo.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://eargo.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://eargo.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://eargo.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://eargo.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://eargo.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://eargo.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://eargo.com/role/DocumentAndEntityInformation" ], "xbrltype": "trueItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://eargo.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://eargo.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://eargo.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://eargo.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://eargo.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://eargo.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://eargo.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 15 0001140361-23-001815-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001140361-23-001815-xbrl.zip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

/9,A^PW7/P+"KMA0J.72/*D4P?\?)FLXU)J*S2%D<$N'3!'E7!!2G=EY& MW.4::N7J A'CT8H?.5)3_/-L>M615<]-5+GR<-IO.OW!_=W]S?6@ [T[N/Y' MIWN+_P8',&70.X!2ZW#G%JZ[M]#O/ T0AUM8 >6^>]/K/_;ZUX/[7O< -O;N M#J"T<]W_M5 M,?CYTYGCH!G1U8V0$R&)YB*\.(FN[(WJ^7$1".J=WP(AAR1$D11(2(&]<+0- M-T@D:B;M)7<&SUSJB('PP:BX90&9$LG@5Q8R20+(:((',BW"B$GFSE(&\YA$ M=SGZ0A2Z$ 1BJMH?BKLF+F[H'@L"-2$>NG-9J!3L^810FIYS>EGXL^8W3UNM M9LMKN:1.??^,T6;#(V>GM$Y\IVJFQ6Q_^_1X]X#@#(SLM^_F4T[UR)Q4?MIZ M:S>_145RH>55IC[!K9K+!'@M07+2;O$=Q' MY'@+$^)*(->$=7QW!R6K?#E4<\DH+\^1_C%M0C*>IU V8[B";!:;E#-#*%:K M@+>G(^Z-[!6!6SX/3;[%">79$;Z9ELWG=0U3DW=8XE*,/AW+>F)8#VLB9V;\ MDTXDV3OI29KFRP" E=85SVSL,AGG7M4I8B!4*W"$MU3D*O9'A(0=S !=1AZ) MJ44R9433(BSSU'5F3#\9\U47LVRVQ-^Y48NG V7L.J9[_IU][3N-MSZ#_8Y(/NX_SOL@QRSDE$VZVQCK 7LG((PPDQW M&0N!1B;-J9B8*3P$XN$P2D*/+H[)P&WT:1.G1&'>/4Z<6MG3M-C?LMA?J/I.'7O!PD_:UT%YIBSNI M+# JL[4D,(*5=AB9PM:(4"/<6ZRZ&S$>HRE/6GA?@.&VA@.X4A$&EL"AD<8H M"ZFU1F+S&]BF.8[N\82$,]/X:LF(BK#@5D9*$?AXS"A':W'_G$B.$[581)R9 MO&SIJA\]U)*U:]F3/R+<3C&?S)P^0V92N&]. JZA&_MG2G7*?!ZB#R[#7#O& M?2$(\-BRV9A8*D/;)+.[CVG@J?'CR&SKZ#(8O_Q(6C"(IX]Q]T>%(F0Q<&NX MK=AOEGJC_7-P%XB\!>55G7,D[$V+QU(S ;9/RPF 5;!1+='F?HS8$D;K,*RZ M"I-(JHC$M+NT0@N[%L(ITTR.S4(MP$@<_RR(I+82XFB"%E)9UIM$;H"DB("$ MH8BP%%M#*@VX+>(L+WJ60>L*\"6QN8]!EX V-S]92EP;8EK *-#&8-2.Q:(G MPC AC7FQF(-%&?D: LXB,Q/-7^"PKC"2$'/7E>*+&85_-OQ#8=:'80J)"(?;BU..3J#_ M2$'FK=4: AM\+2ZM4XSBA)BEQ.T6%U,C;@O_/:)&R\F.M3:-/*.A#4?\.-Y: M5(3.IUA9$#<'9Q'&:"%'6^*P.>*I%"/>"X1]?Z8EL9F(@>3-'QVL94E"W^E@ MBGXLTQ[#V+3BY@\\_)R0S#$I8],"C;Q0+<,U!J,PU8I"A08"SY;FBPHC3V%V M$2PO>B1"R9G+)OZKS7-#.214OB'!H=ENXD<=0RS3);$I9A, 0H39%>*+B0=I MGH5*ANXK$QV)"7F\8ZZOA;,EF#B@[<+&PS-,F<-7<2"-R#.+V[8L8Y635$YW M[>_[B?C[US7W7?C]?M#M/#W![[]U^AWSRN(]ZIOBTG,_TU';(*.OU#-)HN]> M<2,9*40[SB&N5=*[1[B=2_L"0/@XU81@&)M0;2(GFZ1%47\G843DK&A??Y?_ M&Z&R70<=OP%>--.T2_BEMCE6:UYE M!V2B<$QZ]&$==:-2=IH_;>@RWP[XYM[V?109YW']PLM"[6N-[$;0O?X$YJ/C=7_G/BJ(DYTF8Q>6LP&G M>, M67M;K+?-I=BMK9'9&,)[>KLR?=? 2_[[$6WO%VT#\T#C_SS<.//A@0U) +VD M:S*-V/RSBNW#[_U?)^1]<_E^7\:N?A>[+]@98ZW@C*E6QQL^0'8.]P'R?F#$ M*Y7@>W%B/B2W!\E7\?\!4$L#!!0 ( *6!,58XGNFU0@T )PL 7 M8G)H8S$P,#0V-C,R7V5X.3DM,2YH=&W56FEWV[@5_=YS^A]0IYW)G"/)DF?2 MQ$M\QG&<-E,WR=BS?(9(4$),$AP E*S^^M[W %+49L<9MVF=Q1()/KSUO@4\ MF?HB/_WC'X0XF2J9\B=\]MKGZO1D/_R.%__4[XM+G:C2J51X62-3J].) M"BOXY[5)ZD*57B1628^5M=/EI+-6?+AZG^EF6E@] MF7HQ.CQ\)OKB8'CP;??Y?C\PO!\Y/AF;="'&D\3DQK[<>Y+QSYYP?I&KEWN9 M*7T_DX7.%T?BZY]TH9QXI^;BRA2R_/I8\'VG_Z6.Q&A8^6/AU:WORUQ/RB.1 MJPQ7F/*1>#+DG^.]L'^J9XUJIE:4QDUEBOWBASW!)%[N06%>V9:=J2+9CL1W MU>T&83&6RBD':BRSXQ>21D[4U[R89-PK6QL:D"K=*4 M*C*_PG[XTC#8W8C)1!4]1(5\81XE'9L\Q;87MU,]UEX<'@Y&)_OKNY^>C.WR MPL;M;+A[.]=WI]]D[\\/[ZHB?.02P;],0/LAR(T?->B)"G?[M\ M_^I"O+OX]?K7MU<7WXBOGKPX&(V.!0O7$V_+9"">TL6#X3%?X\]88*SP4R7B MK7-35+);TP)=W3SFE\ M\D;HHK)FIICT;S58]HMEE)M,0 8%,:VHE*D !W/MIP(A;0DN=I1Z;V:BL5,0A3\PVB M4Z:PMO.,6&LDH3AC*V.E)\F832)]K8!P7MH%K;GV<3'?:;Z\5KF<2ZMH-\7. M1?>76J@L5&AJEW>%;+W/1N]S['V.O*_9H6.CT?-C1S8HP%M8V15\BP(='#8*/,_ MI;U17EQ>GK?.'^ZWK@"?*L(B4ZF2B""P:C+LZ$6(K0&179KM3M;G.L]QI?2Z MK-GPQ+8BJI$M@+L* =<(Y!8%<*@Q&<(LLM83X]H'@H'(\M',Y+F9T\,E-'W^ M\_7;#Z*LBS'!_,'SX?#%\X/ABR]HX3,'&UGEZKSUV2VNV!-T;0$="^1,+*>U M:X[@ZAB>IO:(SY(U)EU#-825)IP!6\W5)0JP]L:*,V&!" 9PY1TE M!0%*6!O!IF1+.4:6KBM31O^*3QJ[5.,,SLH0G7$P=$,VQ+.IB$''&Y%G8U>" M[W 3X8+@0,),D?OG4PT[L"]%X37A?D=*JD"HR7"JB8\-MC\E76*=LC,P0;4( MRXDT'.3LR-@5C3UD0YZ5:+I#,"SM-0PGQ#Q1[!+KK8NIRU4QUXP6E;W)U0"E M"QPAU?2MMUU#.Z1O$\VZZM1O-0HY4>424NN":D&X&Q .O% =:99J> @\6Y76 M5/RL.'&^^,(U2B5A=YG7+>.;F=ZJ0L(L*-VFLIP0W'GQY^$ +=NH$V8R\U&? M6T-W,^R0KJ;&@I]T5V:DW;LNQVQ@\^^>#5&%YSG5JN'1ARCQ=$GR[K:K;4_/ MZ,\CM6%G8R!&Z%=66;N+Z\^1H?6+WRM&TSIJ]_#&J.EU\#OWTX%X7R,"T0;, M) <,%B$F?,#*B>E[TX]EJJQP3R+:$=NPKV/?*>3'+A(+ 8?,&N:0 +@J0DKP-4FT13XO-Z4DAX9Y)@$_3NU,(Q-XEQ2-B_4B)&U@2O M!JP'171H.\Z^7*UJBR)FIJVOJ?S"5C,-@KGJ4>Z&DTZ4Y&^DLEQ1Y/=UV4\D MN.V)-Z_/^E9-ZIR;LZ!<*E52[M XK=-SJG3XVM4 01HLR2L* T2CQ-CM,(/. M4PV0LE0E$#EBHG1UH6P_L-UJ6Q65F5-QTBQPG$_EC>)ZWZ*$#S"A;;/+ /C9 MK(4THJHMQ"7,+W-=0F $+#61.@<_B0RY!%S#/0)<5%.J1]D#8'@ BB,+,BX$ M0Y0S5>J54D8$_G(?^E5:YNJ*4!55C2E:!4"J3+%3RMS!.#)LUN-)$ZK)@KBB MQ*=39KBY AX(\-BCH?\:Q2/H; DF*C),)$:^K) M=,5Y"6=+E;LF&?Z,W*K2KOC((V7PN%VX'J2Z9 M79/'2#GPQZ-&,:1QXURG?DJ,#O_23 7[\=KP6#23R8,'3B:[6MH[?01T?IP, MLW=ZI0)D7.KRQFUSAT_8/,KX\,U/ZM.I]]71_KZBH!G V4_VZ]//9.-W95DF M?R2T!^T$K(GNK'7=1E^&I;WW]_KU ]'V M40KWK77E.\-#$JERYF@D(#W_GVCH#.#1B\\@.ZS=40S7);I6LE+K+?6SK#UO[7AY' MQPIMN70^5>6Z"C:;Q"WSZPHU4#_,]-O9=1@0#\0)V7_E^'+#P>]PGHW#RC>[ MG8,411/)22VM++T*O4)6^]KRE(BFESP0(,/38E>//_(QAA%6NQO7ZPHNJ U6 MEDS##L /.92#<4C"L\B$9WF)K,E."34$[?21UJ.;(,9 /Y3E@HI'J[EMX/(5 M?3$]B1T2786"O35G&)B30+DN=.@->I'1>WBSL5:@<^V3?=+QZ2.9(>2%O=/N M4-;$\5;'TSB>:5!-4S8LF $T4L)^E-#4?RE62E/)TX.P1=-54C&=2UTX[GFL MTL6XMB[@7-2:$F\N_OZ*J$VL++C)X'#3J-:BOKX 90;\:U?)ZO&;N9 M6JR'BHR=(G5=I&X"*!HN+:=8S8X)]3DTZ ;_FZW%<3@D@24I:&SK)EALRHFA MJU%HRMO1?YH>/$R/R:XSK>9.C!<$%(B"2EJ:7\F%L7$'].,RB;/5M15=RFM1 M3C,7[DD-LDJ.!2Z153C0[/;73;MJMD_PQ_1V!$%7'(BV E8JG#=&'N^$(\ A M7#L,Z=.V4>+RG@57MSK,+A,D($/-V2<0787#RGAND//FJ(Q"877J23]\->:3 MY2--3XA+51U+EC!O]&YUS$%QT*!/O-Y%ZX=YSAU^V20*.CQ;[6:C3W?P161* M$D=L%SZTH4'KRG:K2H#)56ZJB+ E#S4_AJ09<8:U:G:-IJDGAE>%9S6?RJ0P MG%UT5;'LG1M%W2MT&XQ$L]F'1[,JF9: JPE'CDQGDH^?\/ $R]&KDYH@#:4( M1H0F8WB#!$L:;@XXVA<%ZQ/>*N8,U M9JJ=(46-W*W3%?;X?8# (U/ADJ?!T,\'C*ZM(TCEC.=AJA-C[/U/YRL/=W;( M .5J;NS-;IRFI.*(9J]5*Z\-B$N,\3Q.L_K:]Q[(&2P= ]A01!SOW(!.3"A] MNPTU= NM][^\?=T?'0)P4106.KDWGY,5T]HNQUOLCA'$/Q=F!X^;])O:B\Z, MW1:@#+F7*Q.JJ^+F,+Y+K!Z'PG;"+]!97.0!X?),QL4*/!YK-J]Z@)AX R4 M.IHW>]8*Y4W%G)4E56!7BJL*T$2Q6$#8_C]853^B+@0+J+W""M==\N-.PP?I M,KA4.7$K;\PTO0$]V?0'7/>NU\T?>@X]_%>-%V?]72^+3\WGT[VZ35>_A#?2?XW4$L# M!!0 ( *6!,5983J$+1 , "X/ 0 96%R+3(P,C,P,3$W+GAS9+57 M76_3,!1]1^(_F+SGJUV!5NLFT#8T:3 T0.(-N7 MK\+P W"06$.&)BOT7@J<29K- 'U^>IQ2!JC7BU+SBP9I,JC9P]#Z+]5(D3GD M&&DL9Z _X1Q4@0F,@[G6Q2B.P:R+B(@\[B6]?I*F;XP:!CEP?2=D?@-3O&!Z M'/Q:8$:G%+( &?E/O'Q^^N*@>:X(<#5BB&.4_ M&YS+B62>M1];\P0K6 O8P5<:TN%P&#OK&FJ(Z!%JRI7&G$ =G^FU0QT\B$NC MAYKSTJL"-LF88C5Q8&^Q^^QYN)+Z$'YM:CAD0)LZ%)!H)G['QM $:KG%W-BG M,[OH3[$ M/$,E':KQ7<;;)-O\"P79([]RX^WBJ+PKR#%/@AE9L#,<-\H.^U6K_@1\/\5; M#54N--O.-IVI-R$UXCOW=/U:F6%<5+U?WNX/@CB:$JW\5;'7)P:FE5^QA=R+ MEBKS-714PX'[YZB&;;@==(A*Q()KN6H3N>[B)UT4+*0TG^MV$NH^ZUD'$; D M\S8"UG@WZA"88TI4F\@;AW+8(;:BI$UD#[>#=E&W+^YA>5MRF-EWV/[PVVY, MRH97:'G"M!>FK[OKT*TUZ'/B-].I"]DJ_1[O1MT.H/Y".V7CSL7.0N]GM]^W MV^^G9ZNXB*7]6I\HP*%MV(LP>1NF2;NL[[PV3XSJ'6S@P1$8?T2$L"X8YUD*N[LS\]!:HL]QN2,[IB/ICO56./+[,CWWJMTK-P3\) MYT;O>CS[_DX<%/,W3S=7&R'N<5227?T!4$L#!!0 ( *6!,5:],V+!O@@ M &%; 4 96%R+3(P,C,P,3$W7VQA8BYX;6S-G&MOVS84AK\/V'_@O"\; M4,>QC Y(T+C(W'0(EB9!DF(W#(4LTXXP60PHN7'^_4A)M$7RD%(J2A90-([. M>U[>GB/:DJ-W[[?K"'W%- E)?#88'QT/$(X#L@CCU=E@DPS]) C#P?OI]]^] M^V$X_ W'F/HI7J#Y"_J5$G]!P\4*H]N[FV488>1Y1V/V[^CM^/AM*3X<\OPH MC/\[Y?_-_00CUFZ7B/_\ M?'=IS#X9<<4HQNF5/\<1:S)+3U^>\-D@"==/$1;''BE>PCX1I3L;/CLG?';& MO_#9^7'O/&K2O16GZ8&D?N2FGYF?WE>MF>:=OG8UM;8N7[N<95;EN(-9+C73 MO-.WF(9D<1$OVN^XVI2KSM^G/NT %;VQY@-HO]= 5R-^Z(J]DMK%VQ3'"[P0 M+7-OR[DS:SH[V6;..V\22*X1WT4(U8>3,-?,,<'!T8I\'2UPR)P]C[\8\A?9 M*-@O7V:$[9_G\R2E?I *IVP09P,PEH8I[[L2&\D=Y?E25RE.R(8&6&E!Z\&7 M:!Z]:I*D-*)!E*"3+DCEHG[@,) M-FL8F(LTYTR*$Y-AA M&;6O&JDYR3*UH%S@:_%JG^-[$H5!F+(/M)_8&PX:^I&"E%E0#!$2-,!7MW/% MKM'9!*XA8;H_CD3@L,A:UHC4F5495ETK2#6YM(_I+<6\/C";@NQ,S]_LTIOE M$E,%H6IA,5B;L &^9EM7&%>V8,*Y(G'*XL.@)$"Y F62PP)>8U7):^9?!MZ< M(\"O0POMU] Y:WW!>_ Q\E<*J&"L&*X2:U *DI,K[B%3$^2Z=KH[ MA/BQP[(+KP*IF#R92DDF$ 1RN[L0\3%, C_Z"_OT(SNB?DJL4"F7)S25@RL5 MBJ?KBQ:P?=7U"RAK?RDCCR(>1EF\']4EUS;X5QOH![I:I[&>B[H'^W0>H*\&Z;>1GPI!69>\^R.^MT- ML0_LL["!>%"CT*YH') N.;JF'#*O(ES/V=-=8,V"B$?[03:\;J3F-,-$2W*5 M9L"K?9(O8M;3ESN\"OD-FCB]]M0?L0 MXK'#$FQ=,%)O@F5^(;7 U^S4%;TS5CS4CR[9A\GM[_@%Q->@D?C5-(T!5AS= M$@R;VQ&&<@3#10QE0<2B?:#8M&ZDYC1#'"MR&630JRN2/X81OMZLY]JU/%-8 MXK<<;HSNWLPMM9JO'5A%+ECEAU%^O ^4 @M#JB<38G.OE+%4';HB\L'?7BY8 M283+XJZD!<\*K<2J4=L87(.S6XKMC=B1MN4*OID&R:(>T5ZUSN25RP'5@2%- M+@JK=U<5M&%1T\<963_Y,?S!UJJ4-A&#LO'F ?JZW31L3=@W M"W.FV"2$ N425&CZL"_8UY:\:A&@?0!,DL__%M^N:N%\L6 ,)L6/JS#&8[ 2 M+#JI#D!=XRH 7-W6@+D!>P68\@3_1>"->(&X!-W$O7AG9%M3\HKIA^@'4F3V MC9Z'(]^K2;Y7DWRO%?*]MLGWOI%\KP;Y#\^DG^1[=OI67]2E_W)Z]F?5+$_.0C[,_;RACZ0Y]A& MOJZ"N"^K7%&_]VR%>N8 M\.QRT@V]I>1K&&O U9%"K&M25\ KQJU0#[=1"WTH5>-_=PE4R'I4!*8UABK! MLA:6>76*WG?5D"GO2%Q-D9/S=LYW0O>=<[UY=2]!-]'NP1 MWNJ*@2=X?89M9_?B-@9X:B\[=8SO+4E2/_H[?#+> ;,)(905H2N@)=M6L(9: MJ 6WGJ@AGDL0T_3F1I9U72'@C2M@P5[* >$'7#NX2<7;I]@'H(="XF:4%&IR M ZIDY.RFD^YIO-&D2J?96VU^J =T@@M [!.GW#8JJ7:WBK3,]BGC#W6+;A]) M#']/S!0N!J.'&Q"GFKFBSN!K(@^43[.C*#O&5$^F3**J%#3"#AT\ M/0('&\HJ8>S-'WA'%5),X6)0>KC)!.C0/I;7Y('Z_"&=]R_K.8F /_>U*(JA@8H& M? )^KA U6YLH-65,KPDJ(B@/]>"/@FUK16I-KDPK(!; &GW:9U9J6.$'C!6# M4F(-")6<7+$)F9JHU+53&<;#<@BO JF8/)D]22:H W*[V[HOML$C6PP,_/&7 M3:)LX;+$P39>-G2]E0/>5=NYEC(5$21"/?CC+^N"D7H3#._L9;6ZN^M.Q?-* M2W-QQ5[QIUP7A\+\J=#3_P%02P,$% @ I8$Q5F@7,83^!0 Z4 !0 M !E87(M,C R,S Q,3=?<')E+GAM;-5<74_C.!1]7VG_0[;[W(:DR\R"Z(S8 M#HRJ9: "5OOQLG(3M[4VL2LGA?+OUTYM:!P[3OD87:01E-SCZWM\CI/FIIV3 MSYL\"^XP+PBCHUXT..@%F"8L)70QZJV+/BH20GJ?/_WXP\E/_?Y73#%')4Z# MV4/P&V!")?X/#Z.!P)][OR_$9H?\=RQ\S5.! S$N+ MXTU!1KUE6:Z.P_#^_GYP/QPPO@CC@X,H_.O;Q4VRQ#GJ$UJ4B":X%PC\<5$= MO& )*JNB=X9O9CS3"8;AXUQ.A/RKKV%]>:@?Q?UA--@4:4^5*,,=)M'P30.O M.$5'1T=A%7V$BD2D)?4C;;%Z0;!=/\XR?(WG@?S]Q_7$.?HHE(B0XO("S7 F MIJR&EP\K/.H5)%]E6!];4MY!NNF4E MREZGSBI?L];&-"\O^O*UEK:MY,O77&6QR_%W6.6=:5Y>]!1SPM(SFKY]X>94 MKU7\38GX=[!*<[*7$WC[JO[K=^E8<%P)812[$@=I<>%-BFN)4SR9+?1:#:D(] M9<:2VBR9O/@QWE2A$+-4$A0X&2S879AB(F2-8_E"$HXKLN*/?\=,7/9/9T7) M45+J3)F48]2SQD2%DHL1"]^\4+U,MR*C4:U#$')@OI(QE/,1[T#^"IJ#:5%9]G:&$H:(VI=3!B\#1L*]XCHC%4J1@! M5E';[O$R^46 Q=>V?:K^7!PI')O=@3*V>P,%3_ENA#IN M^482I?LO[T;W[4G+K[P%9]6^AH.NOIO47OK7TB@'' )VP/8^Y)QD^'*=SS W MA'>%U=(TP_!D]E#PJ-LZ+&@QE$VH2G>_(X?K$H[,#6I&QBH6K>3Z21V(X52^U?P:D]HPOB* M\8K?C:")QVPMR#R,66K?Y9U&U)S@&0'5%_L0[>023T+EF2/PGKE%FTDJV)(Y MV3Y$:[G8>[ UGSBQ4!W2C5PG;SA3Z=8.Y [=EL)IF@JFA?IU02B.K)9HP=7L M8,5!M8*?5"<;6--H"T!N[[G*CSM:(.YH@?@]6< D]4P+Q$\6@-SS) M%AYRZZ]6?/76]HI/.;LCVX]=.=5W0&T6:$"!^Z"=VCYF:&32CH#?"M1VWM[G MM)X'ZA#K24!#@"MOI[+7]M<9M-+P^X.J\BDK2I3]0U;._D$;T*:Z 02N?1NM M?1Q@Y-$^@-P^E->L4XZ117E;2#_;K87@J=M2NN\9;FVD5A!R2U!^*#J;+AFU M/[YQA=5R-,/PU/10\"C:'*U5A=RTN\')F@LO1O'L5M(T5'6%U9(TP_!4]5#P MJ-H6&W/&Z81E)2"F\ M^@V5F!-DOBUS _09W@* I[*7AN_L;AFO]87Z;5" M#0 G"P !< ( !ZR, &)R:&,Q,# T-C8S,E]E>#DY+3$N M:'1M4$L! A0#% @ I8$Q5EA.H0M$ P +@\ ! ( ! M8C$ &5A